Pyros Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PYROS PHARMS, and what generic alternatives to PYROS PHARMS drugs are available?
PYROS PHARMS has two approved drugs.
There is one US patent protecting PYROS PHARMS drugs.
There are three patent family members on PYROS PHARMS drugs in two countries.
Drugs and US Patents for Pyros Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pyros Pharms | VIGPODER | vigabatrin | FOR SOLUTION;ORAL | 214961-001 | Jun 24, 2022 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Pyros Pharms | VIGAFYDE | vigabatrin | SOLUTION;ORAL | 217684-001 | Jun 17, 2024 | RX | Yes | Yes | 12,016,857 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Pyros Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
United Kingdom | 202103724 | ⤷ Subscribe |
World Intellectual Property Organization (WIPO) | 2020039262 | ⤷ Subscribe |
United Kingdom | 2591389 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.